Inventor · disambiguated record
Manuela Kaspar
Also filed as: KASPAR MANUELA
6 granted patents·6 pending applications·42 citations·filing 2007–2019
81Inventor score
Top patents by PatentIndex Score
12 records- 0189US8404814B2Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritisNERI DARIO·Filed 2007·Granted Mar 26, 2013·20 cites·12 claims
- 0286US8222377B2Antigen associated with rheumatoid arthritisKASPAR MANUELA·Filed 2008·Granted Jul 17, 2012·13 cites·5 claims
- 0383US9446124B2Targeting of bone marrow neovasculaturePHILOGEN SPA·Filed 2014·Granted Sep 20, 2016·3 cites·7 claims
- 0480US8679488B2Targeting of bone marrow neovasculatureKASPAR MANUELA·Filed 2010·Granted Mar 25, 2014·4 cites·9 claims
- 0573US9556257B2Antigen associated with rheumatoid arthritisKASPAR MANUELA·Filed 2012·Granted Jan 31, 2017·2 cites·31 claims
- 0668US2010215615A1Immunocytokines for cancer treatment in combination with chemotherapeutic agentsPHILOGEN S PA·Filed 2008·Application pending·0 cites
- 0766US2015010498A1Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic AgentsPHILOGEN SPA·Filed 2014·Application pending·0 cites
- 0860US2019352384A1Antigen associated with rheumatoid arthritisPHILOGEN SPA·Filed 2019·Application pending·0 cites
- 0959US10385121B2Antigen associated with rheumatoid arthritisPHILOGEN SPA·Filed 2016·Granted Aug 20, 2019·0 cites·38 claims
- 1054US2014341844A1Immunocytokines in combination with anti-erbb antibodies for the treatment of cancerPHILOGEN SPA·Filed 2014·Application pending·0 cites
- 1152US2013108581A1Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic AgentsPHILOGEN SPA·Filed 2012·Application pending·0 cites
- 1242US2012107270A1Immunocytokines In Combination With Anti-ErbB Antibodies For The Treatment Of CancerKASPAR MANUELA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuela Kaspar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →